Maryam Izad

1.0k total citations
48 papers, 809 citations indexed

About

Maryam Izad is a scholar working on Immunology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Maryam Izad has authored 48 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 17 papers in Pathology and Forensic Medicine and 12 papers in Molecular Biology. Recurrent topics in Maryam Izad's work include Multiple Sclerosis Research Studies (11 papers), Immunotherapy and Immune Responses (8 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). Maryam Izad is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Immunotherapy and Immune Responses (8 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). Maryam Izad collaborates with scholars based in Iran and Canada. Maryam Izad's co-authors include Zahra Salehi, Maryam Azimi, Mohammad Vodjgani, Mojdeh Ghabaee, Mohammad Ali Sahraian, Abdorreza Naser Moghadasi, Joseph M. Antony, François Mallet, Christopher Power and Kenneth G. Warren and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Genomics.

In The Last Decade

Maryam Izad

47 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maryam Izad Iran 16 373 268 134 117 90 48 809
Sainan Zhang China 18 372 1.0× 301 1.1× 35 0.3× 140 1.2× 73 0.8× 83 1.0k
Blake M. Warner United States 18 313 0.8× 153 0.6× 64 0.5× 82 0.7× 34 0.4× 61 1.0k
Huihui Ma China 22 493 1.3× 258 1.0× 72 0.5× 223 1.9× 31 0.3× 66 1.2k
Maryam Shahhoseini Iran 19 446 1.2× 266 1.0× 29 0.2× 83 0.7× 44 0.5× 87 1.2k
Lizhi Hu China 20 326 0.9× 172 0.6× 132 1.0× 53 0.5× 30 0.3× 61 1.0k
Avninder Singh India 16 188 0.5× 96 0.4× 82 0.6× 51 0.4× 61 0.7× 53 821
Zahra Salehi Iran 15 339 0.9× 102 0.4× 89 0.7× 108 0.9× 18 0.2× 78 751
Deborah Clarke United Kingdom 22 444 1.2× 591 2.2× 53 0.4× 207 1.8× 34 0.4× 32 1.7k
Giacomo Lucivero Italy 16 119 0.3× 238 0.9× 112 0.8× 66 0.6× 187 2.1× 48 840

Countries citing papers authored by Maryam Izad

Since Specialization
Citations

This map shows the geographic impact of Maryam Izad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryam Izad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryam Izad more than expected).

Fields of papers citing papers by Maryam Izad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryam Izad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryam Izad. The network helps show where Maryam Izad may publish in the future.

Co-authorship network of co-authors of Maryam Izad

This figure shows the co-authorship network connecting the top 25 collaborators of Maryam Izad. A scholar is included among the top collaborators of Maryam Izad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryam Izad. Maryam Izad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aghdaei, Hamid Asadzadeh, et al.. (2022). New insights into extracellular and intracellular redox status in COVID-19 patients. Redox Biology. 59. 102563–102563. 20 indexed citations
2.
Salehi, Zahra, et al.. (2021). The Association of EBV and HHV-6 Viral Load with Different NK and CD8+ T Cell Subsets in The Acute Phase of Relapsing-Remitting Multiple Sclerosis.. SHILAP Revista de lepidopterología. 23(6). 626–632. 1 indexed citations
3.
Izad, Maryam, Maryam Daneshpazhooh, Hossein Mortazavi, et al.. (2020). Decreased serum levels of interleukin‐17, interleukin‐23, TGF ‐β in pemphigus vulgaris patients, and their association with disease phase. Dermatologic Therapy. 33(6). e14071–e14071. 9 indexed citations
4.
Salehi, Zahra, et al.. (2020). Increased Level of Caspase-1 in the Serum of Relapsing-remitting Multiple Sclerosis (RRMS) Patients. Iranian Journal of Allergy Asthma and Immunology. 19(5). 534–538. 5 indexed citations
5.
Kadkhodaee, Mehri, Behjat Seifi, Ghorbangol Ashabi, et al.. (2020). Adipose-Derived Mesenchymal Stem Cells and Conditioned Medium Attenuate the Memory Retrieval Impairment During Sepsis in Rats. Molecular Neurobiology. 57(9). 3633–3645. 15 indexed citations
6.
Sahraian, Mohammad Ali, Yadollah Shakiba, Zahra Salehi, et al.. (2019). Circulating mesenchymal stem cells, stromal derived factor (SDF)-1 and IP-10 levels increased in clinically active multiple sclerosis patients but not in clinically stable patients treated with beta interferon. Multiple Sclerosis and Related Disorders. 35. 233–238. 16 indexed citations
7.
Azimi, Maryam, et al.. (2019). Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Ace Card to Address Autoimmune Diseases. International Journal of Stem Cells. 13(1). 13–23. 67 indexed citations
8.
Izad, Maryam, et al.. (2018). Alteration in CD8 + T cell subsets in enterovirus‐infected patients: An alarming factor for type 1 diabetes mellitus. The Kaohsiung Journal of Medical Sciences. 34(5). 274–280. 5 indexed citations
9.
Sahraian, Mohammad Ali, et al.. (2018). Characterization of CD4+ and CD8+ T Cell Subsets and Interferon Regulatory Factor 4 (IRF4) in MS Patients Treated with Fingolimod (FTY-720): A Follow-up Study. Iranian Journal of Allergy Asthma and Immunology. 17(4). 346–360. 5 indexed citations
10.
Namdari, Haideh, Maryam Izad, Farhad Rezaei, & Zahra Amirghofran. (2018). Differential regulation of CD4+ T cell subsets by Silymarin in vitro and in ovalbumin immunized mice. DARU Journal of Pharmaceutical Sciences. 26(2). 215–227. 6 indexed citations
11.
Namdari, Haideh, Maryam Izad, Farhad Rezaei, & Zahra Amirghofran. (2018). Thymol as a reciprocal regulator of T cell differentiation: Promotion of regulatory T cells and suppression of Th1/Th17 cells. International Immunopharmacology. 67. 417–426. 8 indexed citations
12.
Keshavarz, Maryam, et al.. (2016). Anti-rubella, Mumps and Measles IgG Antibodies in Medical Students of Tehran University.. PubMed. 15(3). 244–50. 5 indexed citations
13.
Kalantar, Kurosh, et al.. (2013). Serum levels of tumor necrosis factor-α, interleukin-15 and interleukin-10 in patients with pre-eclampsia in comparison with normotensive pregnant women.. PubMed Central. 23 indexed citations
14.
Zandieh, Ali, et al.. (2013). Cytometric profiling in various clinical forms of multiple sclerosis with respect to CD21+, CD32+, and CD35+ B and T cells. Translational Neurodegeneration. 2(1). 14–14. 4 indexed citations
15.
Izad, Maryam, et al.. (2010). Cytokines Genes Polymorphisms and Risk of Multiple Sclerosis. The American Journal of the Medical Sciences. 339(4). 327–331. 13 indexed citations
16.
17.
Jadali, Zohreh, et al.. (2007). Th1/Th2 Cytokines in Psoriasis. SHILAP Revista de lepidopterología. 36(2). 87–91. 11 indexed citations
18.
Antony, Joseph M., Yu Zhu, Maryam Izad, et al.. (2007). Comparative Expression of Human Endogenous Retrovirus-W Genes in Multiple Sclerosis. AIDS Research and Human Retroviruses. 23(10). 1251–1256. 51 indexed citations
19.
Antony, Joseph M., Maryam Izad, Amit Bar‐Or, et al.. (2006). Quantitative Analysis of Human Endogenous Retrovirus-W env in Neuroinflammatory Diseases. AIDS Research and Human Retroviruses. 22(12). 1253–1259. 42 indexed citations
20.
Izad, Maryam, Mohammad Vodjgani, Mohammad Hossein Nicknam, et al.. (2004). Interferon-gamma gene polymorphism in Iranian patients with multiple sclerosis.. PubMed. 3(3). 115–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sainan Zhang Breakdown of academic impact, for papers by Blake M. Warner Breakdown of academic impact, for papers by Huihui Ma Breakdown of academic impact, for papers by Maryam Shahhoseini Breakdown of academic impact, for papers by Lizhi Hu Breakdown of academic impact, for papers by Avninder Singh Breakdown of academic impact, for papers by Zahra Salehi Breakdown of academic impact, for papers by Deborah Clarke Breakdown of academic impact, for papers by Giacomo Lucivero
Rankless by CCL
2026